statistiche ricercatore

Continente	#
NA - Nord America	1.256
EU - Europa	480
AS - Asia	196
OC - Oceania	10
SA - Sud America	9
AF - Africa	3
Continente sconosciuto - Info sul continente non disponibili	1
Totale	1.955

Nazione	#
US - Stati Uniti d'America	1.251
GB - Regno Unito	142
IT - Italia	75
DE - Germania	73
SE - Svezia	67
CN - Cina	52
SG - Singapore	38
HK - Hong Kong	35
FI - Finlandia	24
UA - Ucraina	22
TR - Turchia	21
BE - Belgio	13
IN - India	13
FR - Francia	12
RU - Federazione Russa	11
BG - Bulgaria	10
NL - Olanda	10
AU - Australia	9
TW - Taiwan	7
HU - Ungheria	5
KR - Corea	5
PK - Pakistan	5
ID - Indonesia	4
IE - Irlanda	4
JP - Giappone	4
VN - Vietnam	4
BR - Brasile	3
CA - Canada	3
CO - Colombia	3
MY - Malesia	3
PT - Portogallo	3
BZ - Belize	2
CH - Svizzera	2
IR - Iran	2
RO - Romania	2
TN - Tunisia	2
A2 - ???statistics.table.value.countryCode.A2???	1
AL - Albania	1
AT - Austria	1
BH - Bahrain	1
CL - Cile	1
EC - Ecuador	1
IL - Israele	1
LT - Lituania	1
NO - Norvegia	1
NZ - Nuova Zelanda	1
PE - Perù	1
SI - Slovenia	1
TH - Thailandia	1
ZA - Sudafrica	1
Totale	1.955

Nome	#
Implementation of an NGS-based workflow for BRCA1 and BRCA2 mutation screening	276
A rapid genetic counselling and testing in newly diagnosed breast cancer is associated with high rate of risk-reducing mastectomy in BRCA1/2-positive italian women	241
Collective evidence supports neutrality of BRCA1 V1687I, a novel sequence variant in the conserved THV motif of the first BRCT repeat	225
A novel deletion of BRCA1 gene that eliminates the ATG initiation codon without affecting the promoter region.	212
Double heterozygosity for BRCA1 and hMLH1 gene mutations in a 46-year-old woman with five primary tumors	209
Favourable ten-year overall survival in a Caucasian population with high probability of hereditary breast cancer.	207
FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor	178
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study	170
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores	147
Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness	124
Totale	1.989

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	322	0	0	0	0	37	90	68	42	39	17	18	11
2020/2021	328	35	12	33	35	33	16	19	35	22	47	19	22
2021/2022	273	16	14	33	16	5	22	14	22	35	22	48	26
2022/2023	307	35	40	20	38	31	33	8	36	36	1	17	12
2023/2024	193	7	12	16	14	44	13	21	30	7	4	8	17
2024/2025	122	18	4	12	29	59	0	0	0	0	0	0	0
Totale													1.989